BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23520666)

  • 21. Opportunistic nosocomial multiply resistant bacterial infections--their treatment and prevention.
    Bergogne-Bérézin E; Decré D; Joly-Guillou ML
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():39-47. PubMed ID: 7755661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
    Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
    Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
    Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of
    Djordjevic ZM; Folic MM; Jankovic SM
    Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum procalcitonin predicts Gram-negative bloodstream infections in patients with burns.
    Lin JC; Chen ZH; Chen XD
    Burns; 2020 Feb; 46(1):182-189. PubMed ID: 31859083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
    Casellas JM
    Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and antibiotic susceptibility pattern of bacterial isolates from blood culture in Tikur Anbassa Hospital, Addis Ababa, Ethiopia.
    Asrat D; Amanuel YW
    Ethiop Med J; 2001 Apr; 39(2):97-104. PubMed ID: 11501295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Burn-associated bloodstream infections in pediatric burn patients: Time distribution of etiologic agents.
    Devrim İ; Kara A; Düzgöl M; Karkıner A; Bayram N; Temir G; Şencan A; Sorguç Y; Gülfidan G; Hoşgör M
    Burns; 2017 Feb; 43(1):144-148. PubMed ID: 27615546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiological data for patients with febrile neutropenia.
    Kanamaru A; Tatsumi Y
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S7-S10. PubMed ID: 15250014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
    Chong Y; Yakushiji H; Ito Y; Kamimura T
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.
    Dijkshoorn L; Nemec A; Seifert H
    Nat Rev Microbiol; 2007 Dec; 5(12):939-51. PubMed ID: 18007677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.